Jason Russell Chambers, Director at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), bought 900 shares at $4.66 ($4K) on 2008-09-12, disclosed to the SEC on 2008-09-15.
Open-market purchase of $4k HRT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.55 | 500 | $2K | 55.1% |
| 2 | $4.60 | 200 | $920 | 22.3% |
| 3 | $4.66 | 200 | $932 | 22.6% |
| Total | $4.59 avg | 900 | $4K | 100% |
| Filing → |
| HRT | SELL | 2015-06-16 | $8K | — | Filing → |
| HRT | SELL | 2014-08-14 | $37K | — | Filing → |
| HRT | BUY | 2008-09-16 | $32K | — | Filing → |